Aroa Biosurgery Ltd
ASX:ARX
Balance Sheet
Balance Sheet Decomposition
Aroa Biosurgery Ltd
Current Assets | 73.2m |
Cash & Short-Term Investments | 35m |
Receivables | 30.2m |
Other Current Assets | 8m |
Non-Current Assets | 39.4m |
PP&E | 21.2m |
Intangibles | 18m |
Other Non-Current Assets | 200k |
Current Liabilities | 9.3m |
Accounts Payable | 3m |
Accrued Liabilities | 3.6m |
Other Current Liabilities | 2.7m |
Non-Current Liabilities | 6.1m |
Long-Term Debt | 5.9m |
Other Non-Current Liabilities | 200k |
Balance Sheet
Aroa Biosurgery Ltd
Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | ||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash & Cash Equivalents |
4
|
4
|
4
|
15
|
6
|
10
|
|
Cash |
4
|
4
|
4
|
15
|
6
|
10
|
|
Short-Term Investments |
0
|
0
|
1
|
22
|
51
|
36
|
|
Total Receivables |
3
|
5
|
7
|
7
|
17
|
26
|
|
Accounts Receivables |
1
|
3
|
4
|
3
|
10
|
23
|
|
Other Receivables |
1
|
2
|
3
|
4
|
7
|
3
|
|
Inventory |
2
|
3
|
4
|
4
|
4
|
5
|
|
Other Current Assets |
1
|
1
|
2
|
1
|
1
|
2
|
|
Total Current Assets |
9
|
13
|
18
|
49
|
80
|
78
|
|
PP&E Net |
5
|
6
|
9
|
13
|
15
|
21
|
|
PP&E Gross |
5
|
6
|
9
|
13
|
15
|
21
|
|
Accumulated Depreciation |
2
|
3
|
4
|
5
|
6
|
8
|
|
Intangible Assets |
0
|
15
|
14
|
13
|
12
|
12
|
|
Goodwill |
0
|
6
|
6
|
6
|
6
|
6
|
|
Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Assets |
0
|
6
|
6
|
6
|
6
|
6
|
|
Total Assets |
15
N/A
|
39
+159%
|
46
+16%
|
80
+73%
|
113
+41%
|
117
+3%
|
|
Liabilities | |||||||
Accounts Payable |
1
|
0
|
1
|
1
|
1
|
2
|
|
Accrued Liabilities |
1
|
2
|
4
|
4
|
5
|
5
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
1
|
1
|
11
|
1
|
1
|
|
Other Current Liabilities |
1
|
5
|
29
|
0
|
0
|
0
|
|
Total Current Liabilities |
2
|
8
|
35
|
15
|
7
|
8
|
|
Long-Term Debt |
1
|
0
|
3
|
6
|
5
|
7
|
|
Other Liabilities |
10
|
19
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
13
N/A
|
27
+106%
|
38
+40%
|
21
-45%
|
12
-43%
|
15
+20%
|
|
Equity | |||||||
Common Stock |
20
|
29
|
29
|
97
|
146
|
146
|
|
Retained Earnings |
18
|
17
|
23
|
41
|
46
|
44
|
|
Unrealized Security Profit/Loss |
0
|
0
|
1
|
2
|
1
|
1
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
2
|
|
Total Equity |
2
N/A
|
12
+538%
|
8
-37%
|
58
+669%
|
100
+72%
|
102
+1%
|
|
Total Liabilities & Equity |
15
N/A
|
39
+159%
|
46
+16%
|
80
+73%
|
113
+41%
|
117
+3%
|
|
Shares Outstanding | |||||||
Common Shares Outstanding |
300
|
300
|
300
|
301
|
342
|
343
|